Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction

This publication has 39 references indexed in Scilit:

• Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction
  Progress in Cardiovascular Diseases, 1999
• Natriuretic peptides in assessment of left-ventricular dysfunction
  Scandinavian Journal of Clinical and Laboratory Investigation, 1999
• Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population
  The Lancet, 1997
• Brain natriuretic peptide predicts mortality in the elderly.
  Heart, 1997
• Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure
  The American Journal of Cardiology, 1995
• Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.
  Journal of Clinical Investigation, 1995
• Clinical utility of transthoracic two-dimensional and Doppler echocardiography
  Journal of the American College of Cardiology, 1994
• Plasma brain natriuretic peptide in assessment of acute dyspnoea
  The Lancet, 1994
• Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
  New England Journal of Medicine, 1984
• Left ventricular volume from paired biplane two-dimensional echocardiography.
  Circulation, 1979